Prognostic value of breast cancer aromatase

Allan Lipton, Richard J. Santen, Steven J. Santner, Harold A. Harvey, Sherry I. Sanders, Yvonne L. Matthews

Research output: Contribution to journalArticlepeer-review

73 Scopus citations


The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

Original languageEnglish (US)
Pages (from-to)1951-1955
Number of pages5
Issue number7
StatePublished - Oct 1 1992

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Prognostic value of breast cancer aromatase'. Together they form a unique fingerprint.

Cite this